neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel smartbeam(TM) laser ...
MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...
At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
INDIANAPOLIS, June 5, 2017 /PRNewswire/ -- Bruker is show-casing several new and innovative, high-performance mass spectrometry solutions for metabolomics, proteoform profiling and toxicology at ASMS ...
Brukers market-leading MALDI system - the first MALDI-TOF/TOF that adapts to your needs The rapifleX is the most advanced MALDI TOF/TOF system on the market today and it is also the most adaptable.
(RTTNews) - Avacta Group plc (AVCT.L), a developer of Affimer biotherapeutics and reagents, announced Thursday that it has entered into a collaboration agreement with Bruker Corp. (BRKR) to evaluate ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results